Anti-HBs Seroconversion Following Withdrawal of Anti-HBV-Active Agents: An Underrecognized Form of HBV Reactivation?

Clin Infect Dis. 2026 May 7:ciag305. doi: 10.1093/cid/ciag305. Online ahead of print.

Authors

Eisuke Adachi¹, Hiroshi Yotsuyanagi¹

Affiliation

¹ Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

PMID: 42095823
DOI: 10.1093/cid/ciag305

No abstract available

Keywords: Cabotegravir plus rilpivirine; HBV reactivation; HIV.